French endocrine diseases specialist Amolyt Pharma SA has entered into a take-over agreement by AstraZeneca.
Cell Culture Grade AB Serum that can be customised to your specifications.
Radiopharmaceutical Therapy (RPT) is offering several advantages over existing therapeutic strategies. The highly sought-after therapeutics require a sophisticated supply chain, as...
London-based virtual drug discovery specialist Relation Therapeutics Ltd has closed another US$35m seed financing...
TREM2, a receptor on the surface of macrophages, reduces necrotic core formation in early atherosclerosis, a...
The biotech and pharma branch is growing steadily. Many companies have full order books for the next few years and...
Life sciences is a priority sector for global economies. And Lithuania is emerging as an advanced innovation hub in Central and Eastern Europe. In the country’s well-established...
Six years after the first approved cell and gene therapy, the field is living a renaissance. 5 additional FDA-approved therapies were added in 2022 and could be doubled in 2023,...
Targeted radiotherapy powered by Biotech
Radiopharmaceuticals have turned into a hot commodity when it comes to M&A financing and deals. Targeted therapies that employ high-energy...
The Swiss Biotech Day is one of the leading biotechnology conferences in Europe and a fixed date in the community’s calendar. In 2023 we welcomed more than 1,800 participants from...